May 17, 2020

NHS Direct app now available in Apple store

Apple
Android
NHS Direct
App
Admin
2 min
NHS Direct App available for iPhones
iPhone users are now able to download the new NHS Direct app following the successful launch of the Andriod version last week. The health app is now av...

iPhone users are now able to download the new NHS Direct app following the successful launch of the Andriod version last week.

The health app is now available from the Apple store and gives users access to official health information and advice.

Thirty-seven symptom checkers are featured as part of the app and users have to answer questions about the symptoms they are experiencing to receive a diagnoses.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

The app then provides self-care advice or alternatively advises the user if they should seek further medical assistance.

If this is the case the app is linked to the NHS Direct telephone service and it can generate a call back from an NHS Direct Nurse Advisor.

Symptom checkers have already proved to be popular online tools and the NHS is hoping that by launching the apps people will be encouraged to self-asses and treat their symptoms based on clinically-proven medical advice.

As a result they are hoping people will be less inclined to use already overstretched local NHS services such as hospital A&E departments or GP surgeries for conditions which aren’t an emergency.

Since its launch on Thursday, the Android version of the app has already been downloaded 1,774 times.

Roger Donald, the associate Director of Multichannel at NHS Direct said of the apps launch: “The NHS Direct app has been developed in response to the popularity of this new mobile channel and to the specific needs of the growing number of patients who prefer to access health advice online.”

Share article

Jun 23, 2021

Introducing Dosis - the AI powered dosing platform

AI
medication
personalisedmedicine
chronicdisease
3 min
Dosis is an AI-powered personalised medication dosing platform that's on a mission to transform chronic disease management

Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works. 

When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing. 

The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced. 

What is the Strategic Anemia Advisor? 
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease. 

SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool. 

What else is Dosis working on? 
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs. 

What are Dosis' strategic goals for the next 2-3 years? 
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.

What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.

Share article